Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new.

Slaney, Clare Y; Luo, Peng; Kong, Feng-Ming; Guo, Linlang; Zhang, Jian

Slaney, Clare Y; Luo, Peng; Kong, Feng-Ming; Guo, Linlang; Zhang, Jian.

Afiliação

Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
Luo P; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Kong FM; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Guo L; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Zhang J; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

Front Immunol ; 13: 1129623, 2022.

Article em En | MEDLINE | ID: mdl-36713443

Assuntos

Neoplasias; Humanos; Neoplasias/terapia; Terapia Combinada; Imunoterapia

Palavras-chave

cancer; chemotherapy; combination therapy; immunotherapy; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google